1
AS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION ON MAY 11, 1998
FILE NO. 333-47927
================================================================================
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
------------------
POST-EFFECTIVE AMENDMENT NO. 1
to
FORM S-4
REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933
------------------
BAXTER INTERNATIONAL INC.
(Exact name of registrant as specified in its charter)
DELAWARE 2834 36-0781620
(State or other jurisdiction of (Primary Standard Industrial (I.R.S. Employer
incorporation or organization) Classification Code Number) Identification Number)
BAXTER INTERNATIONAL INC.
ONE BAXTER PARKWAY
DEERFIELD, ILLINOIS 60015
(847) 948-2000
(Address, including Zip Code and Telephone Number,
including area code of registrant's principal executive offices)
------------------
J. PATRICK FITZSIMMONS
CORPORATE COUNSEL
BAXTER INTERNATIONAL INC.
ONE BAXTER PARKWAY
DEERFIELD, ILLINOIS 60015
(847) 948-3781
(Name, Address, including Zip Code and Telephone Number,
Including Area Code, of Agent for Service)
------------------
with copies to:
JOSEPH J. GIUNTA JAMES C.T. LINFIELD
SKADDEN, ARPS, SLATE, MEAGHER & FLOM LLP COOLEY GODWARD LLP
300 SOUTH GRAND AVENUE, SUITE 3400 2595 CANYON BOULEVARD, SUITE 250
LOS ANGELES, CALIFORNIA 90071 BOULDER, COLORADO 80302
(213) 687-5000 (303) 546-4000
------------------
APPROXIMATE DATE OF COMMENCEMENT OF PROPOSED SALE OF THE SECURITIES TO THE
PUBLIC: Not applicable.
------------------
If any of the securities being registered on this form are to be offered in
connection with the formation of a holding company and there is compliance with
General Instruction G, check the following box. [ ]
If this form is filed to register additional securities for an offering
pursuant to Rule 462(b) under the Securities Act, check the following box and
list the Securities Act registration statement number of the earlier effective
registration statement for the same offering. [ ]
If this form is a post-effective amendment filed pursuant to Rule 462(d)
under the Securities Act, check the following box and list the Securities Act
registration statement number of the earlier effective registration statement
for the same offering. [ ]
------------------
2
The registrant hereby deregisters 1,865,221 shares of common stock, par
value $1 per share, of Baxter International Inc., a Delaware corporation
("Baxter"), and 773,032 Contingent Payment Rights of Baxter, which were not sold
in connection with the merger of Somatogen, Inc., a Delaware corporation, into
RHBI Acquisition Corp., a Delaware corporation and a wholly owned subsidiary of
Baxter.
================================================================================
3
SIGNATURES
Pursuant to the requirements of the Securities Act, the registrant has duly
caused this post-effective amendment to the registration statement on Form S-4
to be signed on its behalf by the undersigned, thereunto duly authorized, in the
Township of West Deerfield, State of Illinois, on the 11th day of May, 1998.
BAXTER INTERNATIONAL INC.
By: /s/ VERNON R. LOUCKS JR.
----------------------------------
Vernon R. Loucks Jr.
Chairman and Chief Executive
Officer
Pursuant to the requirements of the Securities Act, this post-effective
amendment to the registration statement on Form S-4 has been signed by the
following persons in the capacities indicated on the 11th day of May, 1998.
By: /s/ VERNON R. LOUCKS JR.
----------------------------------
Vernon R. Loucks Jr.
Chairman and Chief Executive
Officer
By:/s/ HARRY M. JANSEN KRAEMER, JR.
----------------------------------
Harry M. Jansen Kraemer, Jr.
President and a Director
By: /s/ BRIAN P. ANDERSON
----------------------------------
Brian P. Anderson
Senior Vice President and Chief
Financial Officer
By: /s/ BRIAN P. ANDERSON
----------------------------------
Brian P. Anderson
Senior Vice President and Chief
Accounting Officer
The Board of Directors of Baxter
Walter E. Boomer
Pei-yuan Chia
John W. Colloton
Susan Crown
Mary Johnston Evans
Frank R. Frame
Martha R. Ingram
Arnold J. Levine, Ph.D.
Georges C. St. Laurent, Jr.
Monroe E. Trout, M.D.
Fred L. Turner
By: /s/ HARRY M. JANSEN KRAEMER, JR.
--------------------------------
Harry M. Jansen Kraemer, Jr.
Director and Attorney-in-Fact
II-3